Suchergebnisse - "Gao, Leili"

PubPharm (7)

1

Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes : A randomized, double-blind, placebo-controlled phase 3 trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Ji, L. | Lu, J. | Gao, L. | +12

2

A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology

enthalten in: Diabetes | 2023

von Ren, Q. | Zhang, P. | Pang, W. | +14

3

Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone : A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Gao, L. | Cheng, Z. | Su, B. | +15

4

A multicentre, randomized, double-blind, parallel, active- and placebo-controlled Phase 3 clinical study of the glucokinase activator PB-201 in treatment-naive patients with type 2 diabetes mellitus : A study protocol

enthalten in: Diabetes, obesity & metabolism | 2023

von Du, Y. | Gao, L. | Xiao, X. | +2

5

Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes : results from the Observational Registry of Basal Insulin Treatment (ORBIT)

enthalten in: Journal of diabetes | 2020

von Gao, L. | Zhang, P. | Weng, J. | +13

6

Chinese clinical guidelines for continuous glucose monitoring (2018 edition)

enthalten in: Diabetes/metabolism research and reviews | 2019

von Bao, Y. | Chen, L. | Chen, L. | +31

7

Prevalence of and risk factors for diabetic ketosis in Chinese diabetic patients with random blood glucose levels >13.9 mmol/L : Results from the CHina study in prEvalence of diabetiC Ketosis (CHECK) study

enthalten in: Journal of diabetes | 2018

von Gao, L. | Li, Y. | Fei, D. | +5

1
[1]